AstraZeneca Beats Investors' COVID Vaccine Suit For Good
A New York federal judge on Monday permanently dismissed a proposed class action alleging AstraZeneca misled investors about the progress of clinical trials for its COVID-19 vaccine, finding the investors didn't...To view the full article, register now.
Already a subscriber? Click here to view full article